Vaccine News and Research

Latest Vaccine News and Research

New flu vaccine takes weeks to mass produce

Using cell-based methods researchers have developed a commercially viable method for mass producing effective vaccines against potential pandemic influenza strains in weeks instead of the months required for traditional egg-based vaccines.

17 Feb 2006

Diagnosing whooping cough in young children

Whooping cough (pertussis) is most easily diagnosed in young children because they develop a characteristic cough - paroxysms of coughing followed by a long inspiration that makes a whooping sound.

16 Feb 2006

African countries should step up surveillance and border controls for bird flu

The highly pathogenic avian influenza virus often spreads through the movement of affected birds, FAO/World Organisation for Animal Health (OIE) said.

13 Feb 2006

National childhood flu-vaccine programs should include evaluation component

If the United States were to launch an annual influenza-vaccination program among the nation's school children, resources also should go to evaluate the program's success in reducing community-wide flu transmission, according to a "Policy Forum" editorial in Science authored by researchers based at Fred Hutchinson Cancer Research Center.

12 Feb 2006

Many women who are eligible for rubella vaccination are not being immunized after giving birth

Contrary to federal recommendations, many women who are eligible for rubella vaccination are not being immunized after giving birth, a new study of Miami-area hospitals has found.

7 Feb 2006

Sanofi pasteur delivers more H5N1 vaccines to U.S. Government

Sanofi pasteur has delivered more H5N1 vaccine to the U.S. government including investigational doses formulated with an adjuvant.

7 Feb 2006

New technology for accelerating development of vaccines against H5N1 flu

Technology that enables scientists to identify targets for the development of vaccines against viruses such as H5N1 in weeks rather than months has entered a pilot study at ProImmune, Oxford, UK.

7 Feb 2006

Viragen reports on Multiferon anti-viral studies

Viragen, Inc today reported on the progression of anti-viral studies using Multiferon (multi-subtype, natural human alpha interferon) being conducted by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

7 Feb 2006

Monotherapy phase I clinical trials of novel cytotoxics, targeted therapeutics, antimetastatic agents/angiogenesis inhibitors, and immunotherapeutics/vaccines

Numerous novel oncology agents are currently in phase I monotherapy trials. New Medicine's Oncology KnowledgeBASE (nm|OK) has updated the records of 92 such agents with preclinical or clinical results reported during the 2005 meetings of the American Association for Cancer Research (AACR)

7 Feb 2006

Rotavirus vaccine will protect children against a major killer worldwide

The Food and Drug Administration (FDA) has announced the licensing of a new vaccine against a disease responsible for tens of thousands of hospitalizations in the United States and hundreds of thousands of deaths around the world each year.

7 Feb 2006

Source of crucial immune cell in the skin discovered - may lead to tumor immunotherapy

Mount Sinai School of Medicine researchers have identified the precursors of cells in the skin that are part of the first line of defense against invading pathogens. The study appears on Nature Immunology's website.

7 Feb 2006

Controlling neglected diseases will boost fight against HIV, TB and Malaria

Achieving success in the global fight against the "big three" diseases - HIV/AIDS, tuberculosis and malaria, which together account for 5.6 million deaths a year - may well require a concurrent attack on the world’s most neglected tropical diseases, says a team of researchers in the international open access journal PLoS Medicine.

2 Feb 2006